Quarterly report [Sections 13 or 15(d)]

Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.25.1
Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Share Capital
Contributed Surplus
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2023 $ 302,182 $ 19,881 $ 3,718 $ (250,911) $ 74,870
Beginning Balance (in shares) at Dec. 31, 2023 270,898,900        
Shares issued for cash $ 4,227       4,227
Shares issued for cash (in shares) 2,464,500        
Share issue costs $ (106)       (106)
Exercise of warrants $ 15,849       15,849
Exercise of warrants (in shares) 8,188,250        
Exercise of stock options $ 61 (21)     40
Exercise of stock options (in shares) 74,674        
Stock compensation   324     324
Comprehensive income (loss)     283 (18,541) (18,258)
Ending Balance at Mar. 31, 2024 $ 322,213 20,184 4,001 (269,452) 76,946
Ending Balance (in shares) at Mar. 31, 2024 281,626,324        
Beginning Balance at Dec. 31, 2024 $ 413,242 19,468 4,189 (304,100) 132,799
Beginning Balance (in shares) at Dec. 31, 2024 364,101,038        
Exercise of stock options $ 405 213     $ 618
Exercise of stock options (in shares) 464,807       464,807
Redemption of RSUs $ 283 (343)     $ (60)
Redemption of RSUs (in shares) 253,415        
Stock compensation   668     668
Comprehensive income (loss)     (28) (10,898) (10,926)
Ending Balance at Mar. 31, 2025 $ 413,930 $ 20,006 $ 4,161 $ (314,998) $ 123,099
Ending Balance (in shares) at Mar. 31, 2025 364,819,260